nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2A6—Progesterone—uterine cancer	0.0913	0.121	CbGbCtD
Azelastine—CYP1A1—Progesterone—uterine cancer	0.078	0.103	CbGbCtD
Azelastine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.068	0.0898	CbGbCtD
Azelastine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0474	0.0626	CbGbCtD
Azelastine—CYP3A5—Progesterone—uterine cancer	0.0468	0.0619	CbGbCtD
Azelastine—CYP2C8—Progesterone—uterine cancer	0.045	0.0595	CbGbCtD
Azelastine—CYP2C19—Progesterone—uterine cancer	0.0378	0.0499	CbGbCtD
Azelastine—CYP1A2—Progesterone—uterine cancer	0.0349	0.0461	CbGbCtD
Azelastine—CYP2C9—Progesterone—uterine cancer	0.0314	0.0415	CbGbCtD
Azelastine—ABCB1—Progesterone—uterine cancer	0.0305	0.0403	CbGbCtD
Azelastine—CYP2D6—Progesterone—uterine cancer	0.0287	0.0379	CbGbCtD
Azelastine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0276	0.0364	CbGbCtD
Azelastine—CYP2E1—Etoposide—uterine cancer	0.027	0.0356	CbGbCtD
Azelastine—ABCB1—Dactinomycin—uterine cancer	0.0242	0.0319	CbGbCtD
Azelastine—CYP3A5—Etoposide—uterine cancer	0.021	0.0277	CbGbCtD
Azelastine—CYP2C8—Etoposide—uterine cancer	0.0202	0.0266	CbGbCtD
Azelastine—CYP3A4—Progesterone—uterine cancer	0.0183	0.0241	CbGbCtD
Azelastine—CYP2B6—Doxorubicin—uterine cancer	0.0182	0.024	CbGbCtD
Azelastine—CYP1A2—Etoposide—uterine cancer	0.0156	0.0206	CbGbCtD
Azelastine—ABCB1—Etoposide—uterine cancer	0.0136	0.018	CbGbCtD
Azelastine—ABCB1—Doxorubicin—uterine cancer	0.00931	0.0123	CbGbCtD
Azelastine—CYP2D6—Doxorubicin—uterine cancer	0.00877	0.0116	CbGbCtD
Azelastine—CYP3A4—Etoposide—uterine cancer	0.00817	0.0108	CbGbCtD
Azelastine—CYP3A4—Doxorubicin—uterine cancer	0.00558	0.00736	CbGbCtD
Azelastine—ADRA1B—renal system—uterine cancer	0.00102	0.0409	CbGeAlD
Azelastine—KCNH2—myometrium—uterine cancer	0.00076	0.0305	CbGeAlD
Azelastine—CYP2A6—vagina—uterine cancer	0.000653	0.0262	CbGeAlD
Azelastine—HRH1—myometrium—uterine cancer	0.000609	0.0244	CbGeAlD
Azelastine—KCNH2—uterine cervix—uterine cancer	0.000592	0.0237	CbGeAlD
Azelastine—KCNH2—renal system—uterine cancer	0.000554	0.0222	CbGeAlD
Azelastine—KCNH2—endometrium—uterine cancer	0.000535	0.0215	CbGeAlD
Azelastine—CYP2C8—renal system—uterine cancer	0.000506	0.0203	CbGeAlD
Azelastine—CYP1A1—epithelium—uterine cancer	0.000504	0.0202	CbGeAlD
Azelastine—CYP1A1—uterine cervix—uterine cancer	0.0005	0.02	CbGeAlD
Azelastine—KCNH2—uterus—uterine cancer	0.000493	0.0198	CbGeAlD
Azelastine—CYP2C8—endometrium—uterine cancer	0.00049	0.0196	CbGeAlD
Azelastine—CYP3A5—uterine cervix—uterine cancer	0.000489	0.0196	CbGeAlD
Azelastine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000488	0.0027	CcSEcCtD
Azelastine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000485	0.00268	CcSEcCtD
Azelastine—Paraesthesia—Progesterone—uterine cancer	0.000484	0.00267	CcSEcCtD
Azelastine—Dyspnoea—Progesterone—uterine cancer	0.00048	0.00265	CcSEcCtD
Azelastine—Viral infection—Epirubicin—uterine cancer	0.000479	0.00265	CcSEcCtD
Azelastine—Somnolence—Progesterone—uterine cancer	0.000479	0.00264	CcSEcCtD
Azelastine—HRH1—epithelium—uterine cancer	0.000478	0.0192	CbGeAlD
Azelastine—Bronchospasm—Etoposide—uterine cancer	0.000476	0.00263	CcSEcCtD
Azelastine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000476	0.00263	CcSEcCtD
Azelastine—HRH1—uterine cervix—uterine cancer	0.000474	0.019	CbGeAlD
Azelastine—CYP1A2—renal system—uterine cancer	0.000474	0.019	CbGeAlD
Azelastine—Thinking abnormal—Epirubicin—uterine cancer	0.000473	0.00261	CcSEcCtD
Azelastine—Lacrimation increased—Epirubicin—uterine cancer	0.00047	0.00259	CcSEcCtD
Azelastine—Glossitis—Epirubicin—uterine cancer	0.00047	0.00259	CcSEcCtD
Azelastine—Herpes simplex—Epirubicin—uterine cancer	0.00047	0.00259	CcSEcCtD
Azelastine—CYP1A1—renal system—uterine cancer	0.000468	0.0187	CbGeAlD
Azelastine—Fatigue—Progesterone—uterine cancer	0.000464	0.00256	CcSEcCtD
Azelastine—HRH1—smooth muscle tissue—uterine cancer	0.000461	0.0185	CbGeAlD
Azelastine—Pain—Progesterone—uterine cancer	0.00046	0.00254	CcSEcCtD
Azelastine—Constipation—Progesterone—uterine cancer	0.00046	0.00254	CcSEcCtD
Azelastine—Breast pain—Doxorubicin—uterine cancer	0.000459	0.00254	CcSEcCtD
Azelastine—Ulcer—Epirubicin—uterine cancer	0.000458	0.00253	CcSEcCtD
Azelastine—CYP3A5—renal system—uterine cancer	0.000457	0.0183	CbGeAlD
Azelastine—Amenorrhoea—Doxorubicin—uterine cancer	0.000456	0.00252	CcSEcCtD
Azelastine—CYP2B6—renal system—uterine cancer	0.000454	0.0182	CbGeAlD
Azelastine—HRH1—decidua—uterine cancer	0.000452	0.0181	CbGeAlD
Azelastine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000445	0.00246	CcSEcCtD
Azelastine—Feeling abnormal—Progesterone—uterine cancer	0.000444	0.00245	CcSEcCtD
Azelastine—Viral infection—Doxorubicin—uterine cancer	0.000443	0.00245	CcSEcCtD
Azelastine—KCNH2—female reproductive system—uterine cancer	0.000443	0.0178	CbGeAlD
Azelastine—Gastrointestinal pain—Progesterone—uterine cancer	0.00044	0.00243	CcSEcCtD
Azelastine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000438	0.00242	CcSEcCtD
Azelastine—Thinking abnormal—Doxorubicin—uterine cancer	0.000437	0.00242	CcSEcCtD
Azelastine—CYP1A1—mammalian vulva—uterine cancer	0.000437	0.0175	CbGeAlD
Azelastine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000435	0.0024	CcSEcCtD
Azelastine—Herpes simplex—Doxorubicin—uterine cancer	0.000435	0.0024	CcSEcCtD
Azelastine—Glossitis—Doxorubicin—uterine cancer	0.000435	0.0024	CcSEcCtD
Azelastine—Lacrimation increased—Doxorubicin—uterine cancer	0.000435	0.0024	CcSEcCtD
Azelastine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000434	0.0024	CcSEcCtD
Azelastine—Ill-defined disorder—Dactinomycin—uterine cancer	0.000433	0.00239	CcSEcCtD
Azelastine—HRH1—endometrium—uterine cancer	0.000429	0.0172	CbGeAlD
Azelastine—Dermatitis contact—Epirubicin—uterine cancer	0.000428	0.00236	CcSEcCtD
Azelastine—CYP2E1—renal system—uterine cancer	0.000426	0.0171	CbGeAlD
Azelastine—Abdominal pain—Progesterone—uterine cancer	0.000426	0.00235	CcSEcCtD
Azelastine—Body temperature increased—Progesterone—uterine cancer	0.000426	0.00235	CcSEcCtD
Azelastine—Ulcer—Doxorubicin—uterine cancer	0.000423	0.00234	CcSEcCtD
Azelastine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000421	0.00232	CcSEcCtD
Azelastine—Malaise—Dactinomycin—uterine cancer	0.000421	0.00232	CcSEcCtD
Azelastine—Influenza like illness—Epirubicin—uterine cancer	0.00042	0.00232	CcSEcCtD
Azelastine—CYP2C19—vagina—uterine cancer	0.00042	0.0168	CbGeAlD
Azelastine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000417	0.00231	CcSEcCtD
Azelastine—CYP1A1—uterus—uterine cancer	0.000416	0.0167	CbGeAlD
Azelastine—HRH1—mammalian vulva—uterine cancer	0.000415	0.0166	CbGeAlD
Azelastine—CYP2C8—female reproductive system—uterine cancer	0.000406	0.0163	CbGeAlD
Azelastine—KCNH2—female gonad—uterine cancer	0.000403	0.0162	CbGeAlD
Azelastine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000402	0.00222	CcSEcCtD
Azelastine—KCNH2—vagina—uterine cancer	0.000401	0.0161	CbGeAlD
Azelastine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000399	0.0022	CcSEcCtD
Azelastine—Myalgia—Dactinomycin—uterine cancer	0.000397	0.00219	CcSEcCtD
Azelastine—Hypersensitivity—Progesterone—uterine cancer	0.000397	0.00219	CcSEcCtD
Azelastine—Dermatitis contact—Doxorubicin—uterine cancer	0.000396	0.00219	CcSEcCtD
Azelastine—Discomfort—Dactinomycin—uterine cancer	0.000392	0.00217	CcSEcCtD
Azelastine—Mouth ulceration—Epirubicin—uterine cancer	0.000391	0.00216	CcSEcCtD
Azelastine—Influenza like illness—Doxorubicin—uterine cancer	0.000389	0.00215	CcSEcCtD
Azelastine—Asthenia—Progesterone—uterine cancer	0.000386	0.00213	CcSEcCtD
Azelastine—Hypoaesthesia—Etoposide—uterine cancer	0.000386	0.00213	CcSEcCtD
Azelastine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000386	0.00213	CcSEcCtD
Azelastine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000386	0.00213	CcSEcCtD
Azelastine—Pruritus—Progesterone—uterine cancer	0.000381	0.0021	CcSEcCtD
Azelastine—Infection—Dactinomycin—uterine cancer	0.000378	0.00209	CcSEcCtD
Azelastine—Abnormal vision—Epirubicin—uterine cancer	0.000377	0.00209	CcSEcCtD
Azelastine—Mental disability—Epirubicin—uterine cancer	0.000376	0.00207	CcSEcCtD
Azelastine—CYP1A1—female reproductive system—uterine cancer	0.000374	0.015	CbGeAlD
Azelastine—Diarrhoea—Progesterone—uterine cancer	0.000368	0.00204	CcSEcCtD
Azelastine—CYP2C8—vagina—uterine cancer	0.000367	0.0147	CbGeAlD
Azelastine—CYP2B6—female reproductive system—uterine cancer	0.000364	0.0146	CbGeAlD
Azelastine—Eye disorder—Etoposide—uterine cancer	0.000362	0.002	CcSEcCtD
Azelastine—Mouth ulceration—Doxorubicin—uterine cancer	0.000362	0.002	CcSEcCtD
Azelastine—CYP2C9—female reproductive system—uterine cancer	0.00036	0.0144	CbGeAlD
Azelastine—Flushing—Etoposide—uterine cancer	0.00036	0.00199	CcSEcCtD
Azelastine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00036	0.00199	CcSEcCtD
Azelastine—Dizziness—Progesterone—uterine cancer	0.000356	0.00197	CcSEcCtD
Azelastine—HRH1—female reproductive system—uterine cancer	0.000355	0.0142	CbGeAlD
Azelastine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00035	0.00193	CcSEcCtD
Azelastine—Eczema—Epirubicin—uterine cancer	0.00035	0.00193	CcSEcCtD
Azelastine—Abnormal vision—Doxorubicin—uterine cancer	0.000349	0.00193	CcSEcCtD
Azelastine—Eye pain—Epirubicin—uterine cancer	0.000348	0.00192	CcSEcCtD
Azelastine—Mental disability—Doxorubicin—uterine cancer	0.000348	0.00192	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000347	0.00192	CcSEcCtD
Azelastine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000345	0.00191	CcSEcCtD
Azelastine—CYP3A4—renal system—uterine cancer	0.000343	0.0138	CbGeAlD
Azelastine—Vomiting—Progesterone—uterine cancer	0.000342	0.00189	CcSEcCtD
Azelastine—CYP2E1—female reproductive system—uterine cancer	0.000341	0.0137	CbGeAlD
Azelastine—CYP1A1—female gonad—uterine cancer	0.000341	0.0137	CbGeAlD
Azelastine—Rash—Progesterone—uterine cancer	0.00034	0.00188	CcSEcCtD
Azelastine—Dermatitis—Progesterone—uterine cancer	0.000339	0.00187	CcSEcCtD
Azelastine—CYP1A1—vagina—uterine cancer	0.000339	0.0136	CbGeAlD
Azelastine—CYP2D6—renal system—uterine cancer	0.000338	0.0135	CbGeAlD
Azelastine—Headache—Progesterone—uterine cancer	0.000337	0.00186	CcSEcCtD
Azelastine—Increased appetite—Epirubicin—uterine cancer	0.000334	0.00185	CcSEcCtD
Azelastine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000334	0.00184	CcSEcCtD
Azelastine—ABCB1—myometrium—uterine cancer	0.000334	0.0134	CbGeAlD
Azelastine—CYP3A5—female gonad—uterine cancer	0.000333	0.0134	CbGeAlD
Azelastine—CYP3A5—vagina—uterine cancer	0.000331	0.0133	CbGeAlD
Azelastine—Dysgeusia—Etoposide—uterine cancer	0.000331	0.00183	CcSEcCtD
Azelastine—CYP2B6—vagina—uterine cancer	0.000329	0.0132	CbGeAlD
Azelastine—Fatigue—Dactinomycin—uterine cancer	0.000328	0.00181	CcSEcCtD
Azelastine—Back pain—Etoposide—uterine cancer	0.000326	0.0018	CcSEcCtD
Azelastine—Pain—Dactinomycin—uterine cancer	0.000325	0.0018	CcSEcCtD
Azelastine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000325	0.00179	CcSEcCtD
Azelastine—Eczema—Doxorubicin—uterine cancer	0.000323	0.00179	CcSEcCtD
Azelastine—HRH1—female gonad—uterine cancer	0.000323	0.013	CbGeAlD
Azelastine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000323	0.00178	CcSEcCtD
Azelastine—Eye pain—Doxorubicin—uterine cancer	0.000322	0.00178	CcSEcCtD
Azelastine—HRH1—vagina—uterine cancer	0.000321	0.0129	CbGeAlD
Azelastine—Nausea—Progesterone—uterine cancer	0.00032	0.00177	CcSEcCtD
Azelastine—Feeling abnormal—Dactinomycin—uterine cancer	0.000314	0.00173	CcSEcCtD
Azelastine—Ill-defined disorder—Etoposide—uterine cancer	0.000313	0.00173	CcSEcCtD
Azelastine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000311	0.00172	CcSEcCtD
Azelastine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00031	0.00171	CcSEcCtD
Azelastine—Increased appetite—Doxorubicin—uterine cancer	0.000309	0.00171	CcSEcCtD
Azelastine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000308	0.0017	CcSEcCtD
Azelastine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000307	0.0017	CcSEcCtD
Azelastine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000306	0.00169	CcSEcCtD
Azelastine—Malaise—Etoposide—uterine cancer	0.000304	0.00168	CcSEcCtD
Azelastine—Face oedema—Epirubicin—uterine cancer	0.000303	0.00168	CcSEcCtD
Azelastine—Vertigo—Etoposide—uterine cancer	0.000303	0.00168	CcSEcCtD
Azelastine—Abdominal pain—Dactinomycin—uterine cancer	0.000301	0.00166	CcSEcCtD
Azelastine—Body temperature increased—Dactinomycin—uterine cancer	0.000301	0.00166	CcSEcCtD
Azelastine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.0003	0.00166	CcSEcCtD
Azelastine—Cough—Etoposide—uterine cancer	0.000295	0.00163	CcSEcCtD
Azelastine—Hypertension—Etoposide—uterine cancer	0.000291	0.00161	CcSEcCtD
Azelastine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00029	0.0016	CcSEcCtD
Azelastine—Chest pain—Etoposide—uterine cancer	0.000287	0.00159	CcSEcCtD
Azelastine—Discomfort—Etoposide—uterine cancer	0.000284	0.00157	CcSEcCtD
Azelastine—Nasopharyngitis—Epirubicin—uterine cancer	0.000281	0.00155	CcSEcCtD
Azelastine—Face oedema—Doxorubicin—uterine cancer	0.000281	0.00155	CcSEcCtD
Azelastine—Hypersensitivity—Dactinomycin—uterine cancer	0.00028	0.00155	CcSEcCtD
Azelastine—Confusional state—Etoposide—uterine cancer	0.000278	0.00153	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000277	0.00153	CcSEcCtD
Azelastine—Anaphylactic shock—Etoposide—uterine cancer	0.000275	0.00152	CcSEcCtD
Azelastine—CYP3A4—female reproductive system—uterine cancer	0.000275	0.011	CbGeAlD
Azelastine—Infection—Etoposide—uterine cancer	0.000274	0.00151	CcSEcCtD
Azelastine—Asthenia—Dactinomycin—uterine cancer	0.000273	0.00151	CcSEcCtD
Azelastine—Asthma—Epirubicin—uterine cancer	0.000272	0.0015	CcSEcCtD
Azelastine—CYP2D6—female reproductive system—uterine cancer	0.00027	0.0108	CbGeAlD
Azelastine—Tachycardia—Etoposide—uterine cancer	0.000269	0.00149	CcSEcCtD
Azelastine—ABCB1—epithelium—uterine cancer	0.000262	0.0105	CbGeAlD
Azelastine—Bronchitis—Epirubicin—uterine cancer	0.000261	0.00144	CcSEcCtD
Azelastine—Diarrhoea—Dactinomycin—uterine cancer	0.00026	0.00144	CcSEcCtD
Azelastine—Nasopharyngitis—Doxorubicin—uterine cancer	0.00026	0.00144	CcSEcCtD
Azelastine—ABCB1—uterine cervix—uterine cancer	0.00026	0.0104	CbGeAlD
Azelastine—KCNH2—lymph node—uterine cancer	0.000259	0.0104	CbGeAlD
Azelastine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000256	0.00142	CcSEcCtD
Azelastine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000252	0.00139	CcSEcCtD
Azelastine—Asthma—Doxorubicin—uterine cancer	0.000251	0.00139	CcSEcCtD
Azelastine—Pollakiuria—Epirubicin—uterine cancer	0.000251	0.00139	CcSEcCtD
Azelastine—Paraesthesia—Etoposide—uterine cancer	0.000247	0.00137	CcSEcCtD
Azelastine—ABCB1—decidua—uterine cancer	0.000247	0.00991	CbGeAlD
Azelastine—Weight increased—Epirubicin—uterine cancer	0.000247	0.00137	CcSEcCtD
Azelastine—CYP2D6—female gonad—uterine cancer	0.000246	0.00986	CbGeAlD
Azelastine—Dyspnoea—Etoposide—uterine cancer	0.000246	0.00136	CcSEcCtD
Azelastine—Somnolence—Etoposide—uterine cancer	0.000245	0.00135	CcSEcCtD
Azelastine—ABCB1—renal system—uterine cancer	0.000243	0.00973	CbGeAlD
Azelastine—Vomiting—Dactinomycin—uterine cancer	0.000242	0.00134	CcSEcCtD
Azelastine—Bronchitis—Doxorubicin—uterine cancer	0.000242	0.00133	CcSEcCtD
Azelastine—Rash—Dactinomycin—uterine cancer	0.00024	0.00133	CcSEcCtD
Azelastine—Fatigue—Etoposide—uterine cancer	0.000237	0.00131	CcSEcCtD
Azelastine—Pain—Etoposide—uterine cancer	0.000236	0.0013	CcSEcCtD
Azelastine—Constipation—Etoposide—uterine cancer	0.000236	0.0013	CcSEcCtD
Azelastine—Conjunctivitis—Epirubicin—uterine cancer	0.000235	0.0013	CcSEcCtD
Azelastine—ABCB1—endometrium—uterine cancer	0.000235	0.00941	CbGeAlD
Azelastine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000234	0.00129	CcSEcCtD
Azelastine—Pollakiuria—Doxorubicin—uterine cancer	0.000232	0.00128	CcSEcCtD
Azelastine—Haematuria—Epirubicin—uterine cancer	0.000231	0.00128	CcSEcCtD
Azelastine—Weight increased—Doxorubicin—uterine cancer	0.000229	0.00126	CcSEcCtD
Azelastine—Epistaxis—Epirubicin—uterine cancer	0.000228	0.00126	CcSEcCtD
Azelastine—Sinusitis—Epirubicin—uterine cancer	0.000227	0.00125	CcSEcCtD
Azelastine—ABCB1—mammalian vulva—uterine cancer	0.000227	0.0091	CbGeAlD
Azelastine—Feeling abnormal—Etoposide—uterine cancer	0.000227	0.00125	CcSEcCtD
Azelastine—Nausea—Dactinomycin—uterine cancer	0.000226	0.00125	CcSEcCtD
Azelastine—Gastrointestinal pain—Etoposide—uterine cancer	0.000225	0.00124	CcSEcCtD
Azelastine—CYP1A1—lymph node—uterine cancer	0.000219	0.00878	CbGeAlD
Azelastine—Rhinitis—Epirubicin—uterine cancer	0.000218	0.0012	CcSEcCtD
Azelastine—Abdominal pain—Etoposide—uterine cancer	0.000218	0.0012	CcSEcCtD
Azelastine—Body temperature increased—Etoposide—uterine cancer	0.000218	0.0012	CcSEcCtD
Azelastine—Conjunctivitis—Doxorubicin—uterine cancer	0.000218	0.0012	CcSEcCtD
Azelastine—ABCB1—uterus—uterine cancer	0.000216	0.00867	CbGeAlD
Azelastine—Hypoaesthesia—Epirubicin—uterine cancer	0.000216	0.00119	CcSEcCtD
Azelastine—Pharyngitis—Epirubicin—uterine cancer	0.000216	0.00119	CcSEcCtD
Azelastine—Haematuria—Doxorubicin—uterine cancer	0.000214	0.00118	CcSEcCtD
Azelastine—Epistaxis—Doxorubicin—uterine cancer	0.000211	0.00117	CcSEcCtD
Azelastine—Sinusitis—Doxorubicin—uterine cancer	0.00021	0.00116	CcSEcCtD
Azelastine—Visual impairment—Epirubicin—uterine cancer	0.000209	0.00116	CcSEcCtD
Azelastine—HRH1—lymph node—uterine cancer	0.000208	0.00833	CbGeAlD
Azelastine—Eye disorder—Epirubicin—uterine cancer	0.000203	0.00112	CcSEcCtD
Azelastine—Hypersensitivity—Etoposide—uterine cancer	0.000203	0.00112	CcSEcCtD
Azelastine—Flushing—Epirubicin—uterine cancer	0.000202	0.00111	CcSEcCtD
Azelastine—Rhinitis—Doxorubicin—uterine cancer	0.000202	0.00111	CcSEcCtD
Azelastine—Hypoaesthesia—Doxorubicin—uterine cancer	0.0002	0.00111	CcSEcCtD
Azelastine—Pharyngitis—Doxorubicin—uterine cancer	0.0002	0.0011	CcSEcCtD
Azelastine—Asthenia—Etoposide—uterine cancer	0.000198	0.00109	CcSEcCtD
Azelastine—Pruritus—Etoposide—uterine cancer	0.000195	0.00108	CcSEcCtD
Azelastine—ABCB1—female reproductive system—uterine cancer	0.000194	0.0078	CbGeAlD
Azelastine—Visual impairment—Doxorubicin—uterine cancer	0.000194	0.00107	CcSEcCtD
Azelastine—Diarrhoea—Etoposide—uterine cancer	0.000188	0.00104	CcSEcCtD
Azelastine—Eye disorder—Doxorubicin—uterine cancer	0.000188	0.00104	CcSEcCtD
Azelastine—Flushing—Doxorubicin—uterine cancer	0.000187	0.00103	CcSEcCtD
Azelastine—Tension—Epirubicin—uterine cancer	0.000186	0.00103	CcSEcCtD
Azelastine—Dysgeusia—Epirubicin—uterine cancer	0.000185	0.00102	CcSEcCtD
Azelastine—Nervousness—Epirubicin—uterine cancer	0.000184	0.00102	CcSEcCtD
Azelastine—Back pain—Epirubicin—uterine cancer	0.000183	0.00101	CcSEcCtD
Azelastine—Dizziness—Etoposide—uterine cancer	0.000182	0.00101	CcSEcCtD
Azelastine—Vision blurred—Epirubicin—uterine cancer	0.000178	0.000985	CcSEcCtD
Azelastine—ABCB1—female gonad—uterine cancer	0.000177	0.00709	CbGeAlD
Azelastine—ABCB1—vagina—uterine cancer	0.000176	0.00705	CbGeAlD
Azelastine—Ill-defined disorder—Epirubicin—uterine cancer	0.000176	0.00097	CcSEcCtD
Azelastine—Vomiting—Etoposide—uterine cancer	0.000175	0.000968	CcSEcCtD
Azelastine—Agitation—Epirubicin—uterine cancer	0.000174	0.00096	CcSEcCtD
Azelastine—Rash—Etoposide—uterine cancer	0.000174	0.000959	CcSEcCtD
Azelastine—Dermatitis—Etoposide—uterine cancer	0.000174	0.000959	CcSEcCtD
Azelastine—Headache—Etoposide—uterine cancer	0.000173	0.000953	CcSEcCtD
Azelastine—Tension—Doxorubicin—uterine cancer	0.000172	0.000949	CcSEcCtD
Azelastine—Dysgeusia—Doxorubicin—uterine cancer	0.000171	0.000947	CcSEcCtD
Azelastine—Malaise—Epirubicin—uterine cancer	0.000171	0.000943	CcSEcCtD
Azelastine—Nervousness—Doxorubicin—uterine cancer	0.00017	0.000939	CcSEcCtD
Azelastine—Vertigo—Epirubicin—uterine cancer	0.00017	0.000939	CcSEcCtD
Azelastine—Back pain—Doxorubicin—uterine cancer	0.000169	0.000935	CcSEcCtD
Azelastine—Palpitations—Epirubicin—uterine cancer	0.000167	0.000924	CcSEcCtD
Azelastine—Cough—Epirubicin—uterine cancer	0.000165	0.000912	CcSEcCtD
Azelastine—Vision blurred—Doxorubicin—uterine cancer	0.000165	0.000911	CcSEcCtD
Azelastine—Nausea—Etoposide—uterine cancer	0.000164	0.000904	CcSEcCtD
Azelastine—Hypertension—Epirubicin—uterine cancer	0.000163	0.000902	CcSEcCtD
Azelastine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000162	0.000897	CcSEcCtD
Azelastine—Chest pain—Epirubicin—uterine cancer	0.000161	0.00089	CcSEcCtD
Azelastine—Myalgia—Epirubicin—uterine cancer	0.000161	0.00089	CcSEcCtD
Azelastine—Agitation—Doxorubicin—uterine cancer	0.000161	0.000889	CcSEcCtD
Azelastine—Anxiety—Epirubicin—uterine cancer	0.000161	0.000887	CcSEcCtD
Azelastine—Discomfort—Epirubicin—uterine cancer	0.000159	0.000879	CcSEcCtD
Azelastine—Malaise—Doxorubicin—uterine cancer	0.000158	0.000872	CcSEcCtD
Azelastine—Dry mouth—Epirubicin—uterine cancer	0.000158	0.00087	CcSEcCtD
Azelastine—Vertigo—Doxorubicin—uterine cancer	0.000157	0.000869	CcSEcCtD
Azelastine—Confusional state—Epirubicin—uterine cancer	0.000156	0.00086	CcSEcCtD
Azelastine—Palpitations—Doxorubicin—uterine cancer	0.000155	0.000855	CcSEcCtD
Azelastine—Anaphylactic shock—Epirubicin—uterine cancer	0.000154	0.000853	CcSEcCtD
Azelastine—Infection—Epirubicin—uterine cancer	0.000153	0.000847	CcSEcCtD
Azelastine—Cough—Doxorubicin—uterine cancer	0.000153	0.000844	CcSEcCtD
Azelastine—Hypertension—Doxorubicin—uterine cancer	0.000151	0.000835	CcSEcCtD
Azelastine—Tachycardia—Epirubicin—uterine cancer	0.000151	0.000832	CcSEcCtD
Azelastine—Chest pain—Doxorubicin—uterine cancer	0.000149	0.000823	CcSEcCtD
Azelastine—Myalgia—Doxorubicin—uterine cancer	0.000149	0.000823	CcSEcCtD
Azelastine—Anxiety—Doxorubicin—uterine cancer	0.000149	0.00082	CcSEcCtD
Azelastine—Discomfort—Doxorubicin—uterine cancer	0.000147	0.000813	CcSEcCtD
Azelastine—Dry mouth—Doxorubicin—uterine cancer	0.000146	0.000805	CcSEcCtD
Azelastine—Confusional state—Doxorubicin—uterine cancer	0.000144	0.000796	CcSEcCtD
Azelastine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000143	0.000789	CcSEcCtD
Azelastine—Infection—Doxorubicin—uterine cancer	0.000142	0.000784	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000141	0.000777	CcSEcCtD
Azelastine—Tachycardia—Doxorubicin—uterine cancer	0.000139	0.00077	CcSEcCtD
Azelastine—Paraesthesia—Epirubicin—uterine cancer	0.000139	0.000766	CcSEcCtD
Azelastine—Dyspnoea—Epirubicin—uterine cancer	0.000138	0.00076	CcSEcCtD
Azelastine—Somnolence—Epirubicin—uterine cancer	0.000137	0.000758	CcSEcCtD
Azelastine—Fatigue—Epirubicin—uterine cancer	0.000133	0.000735	CcSEcCtD
Azelastine—Constipation—Epirubicin—uterine cancer	0.000132	0.000729	CcSEcCtD
Azelastine—Pain—Epirubicin—uterine cancer	0.000132	0.000729	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00013	0.000719	CcSEcCtD
Azelastine—Paraesthesia—Doxorubicin—uterine cancer	0.000128	0.000709	CcSEcCtD
Azelastine—Dyspnoea—Doxorubicin—uterine cancer	0.000127	0.000704	CcSEcCtD
Azelastine—Feeling abnormal—Epirubicin—uterine cancer	0.000127	0.000703	CcSEcCtD
Azelastine—Somnolence—Doxorubicin—uterine cancer	0.000127	0.000702	CcSEcCtD
Azelastine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000126	0.000698	CcSEcCtD
Azelastine—Fatigue—Doxorubicin—uterine cancer	0.000123	0.00068	CcSEcCtD
Azelastine—Pain—Doxorubicin—uterine cancer	0.000122	0.000675	CcSEcCtD
Azelastine—Constipation—Doxorubicin—uterine cancer	0.000122	0.000675	CcSEcCtD
Azelastine—Body temperature increased—Epirubicin—uterine cancer	0.000122	0.000674	CcSEcCtD
Azelastine—Abdominal pain—Epirubicin—uterine cancer	0.000122	0.000674	CcSEcCtD
Azelastine—Feeling abnormal—Doxorubicin—uterine cancer	0.000118	0.00065	CcSEcCtD
Azelastine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000117	0.000645	CcSEcCtD
Azelastine—ABCB1—lymph node—uterine cancer	0.000114	0.00456	CbGeAlD
Azelastine—Hypersensitivity—Epirubicin—uterine cancer	0.000114	0.000628	CcSEcCtD
Azelastine—Body temperature increased—Doxorubicin—uterine cancer	0.000113	0.000624	CcSEcCtD
Azelastine—Abdominal pain—Doxorubicin—uterine cancer	0.000113	0.000624	CcSEcCtD
Azelastine—Asthenia—Epirubicin—uterine cancer	0.000111	0.000612	CcSEcCtD
Azelastine—Pruritus—Epirubicin—uterine cancer	0.000109	0.000603	CcSEcCtD
Azelastine—Diarrhoea—Epirubicin—uterine cancer	0.000106	0.000584	CcSEcCtD
Azelastine—Hypersensitivity—Doxorubicin—uterine cancer	0.000105	0.000581	CcSEcCtD
Azelastine—Asthenia—Doxorubicin—uterine cancer	0.000103	0.000566	CcSEcCtD
Azelastine—Dizziness—Epirubicin—uterine cancer	0.000102	0.000564	CcSEcCtD
Azelastine—Pruritus—Doxorubicin—uterine cancer	0.000101	0.000558	CcSEcCtD
Azelastine—Vomiting—Epirubicin—uterine cancer	9.82e-05	0.000542	CcSEcCtD
Azelastine—Diarrhoea—Doxorubicin—uterine cancer	9.78e-05	0.00054	CcSEcCtD
Azelastine—Rash—Epirubicin—uterine cancer	9.74e-05	0.000538	CcSEcCtD
Azelastine—Dermatitis—Epirubicin—uterine cancer	9.73e-05	0.000537	CcSEcCtD
Azelastine—Headache—Epirubicin—uterine cancer	9.67e-05	0.000534	CcSEcCtD
Azelastine—Dizziness—Doxorubicin—uterine cancer	9.45e-05	0.000522	CcSEcCtD
Azelastine—Nausea—Epirubicin—uterine cancer	9.17e-05	0.000507	CcSEcCtD
Azelastine—Vomiting—Doxorubicin—uterine cancer	9.08e-05	0.000502	CcSEcCtD
Azelastine—Rash—Doxorubicin—uterine cancer	9.01e-05	0.000498	CcSEcCtD
Azelastine—Dermatitis—Doxorubicin—uterine cancer	9e-05	0.000497	CcSEcCtD
Azelastine—Headache—Doxorubicin—uterine cancer	8.95e-05	0.000494	CcSEcCtD
Azelastine—Nausea—Doxorubicin—uterine cancer	8.49e-05	0.000469	CcSEcCtD
Azelastine—HRH3—Signaling Pathways—ERBB2—uterine cancer	1.59e-05	0.00043	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—DCN—uterine cancer	1.58e-05	0.000427	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.56e-05	0.000423	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.56e-05	0.000423	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—DCN—uterine cancer	1.55e-05	0.000419	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.54e-05	0.000418	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—DCN—uterine cancer	1.54e-05	0.000418	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKR1C3—uterine cancer	1.52e-05	0.000411	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CXCL8—uterine cancer	1.51e-05	0.000408	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—RRM2—uterine cancer	1.5e-05	0.000406	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—HRAS—uterine cancer	1.5e-05	0.000405	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.49e-05	0.000403	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PGR—uterine cancer	1.48e-05	0.0004	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—POLD1—uterine cancer	1.47e-05	0.000399	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CDKN1B—uterine cancer	1.47e-05	0.000398	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.46e-05	0.000396	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—STAR—uterine cancer	1.46e-05	0.000396	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—DCN—uterine cancer	1.46e-05	0.000395	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.46e-05	0.000394	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—AKT1—uterine cancer	1.46e-05	0.000394	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.45e-05	0.000394	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.45e-05	0.000392	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—POLD1—uterine cancer	1.44e-05	0.000389	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—YWHAE—uterine cancer	1.41e-05	0.000382	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.4e-05	0.00038	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.39e-05	0.000377	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CTNNB1—uterine cancer	1.39e-05	0.000376	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.38e-05	0.000373	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—RRM2—uterine cancer	1.38e-05	0.000373	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.38e-05	0.000372	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKR1C3—uterine cancer	1.37e-05	0.000372	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CYP11A1—uterine cancer	1.37e-05	0.000372	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.37e-05	0.000372	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—STK11—uterine cancer	1.36e-05	0.000367	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.36e-05	0.000367	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—POLD1—uterine cancer	1.36e-05	0.000367	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PTEN—uterine cancer	1.35e-05	0.000367	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FBXW7—uterine cancer	1.35e-05	0.000366	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKR1C1—uterine cancer	1.35e-05	0.000364	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—POLD1—uterine cancer	1.34e-05	0.000364	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PGR—uterine cancer	1.34e-05	0.000362	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—DCN—uterine cancer	1.34e-05	0.000362	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—AKT1—uterine cancer	1.32e-05	0.000358	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000351	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—EP300—uterine cancer	1.29e-05	0.00035	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.28e-05	0.000346	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—YWHAE—uterine cancer	1.28e-05	0.000346	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.27e-05	0.000343	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.26e-05	0.000341	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.26e-05	0.00034	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.24e-05	0.000335	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—RRM2—uterine cancer	1.23e-05	0.000333	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FBXW7—uterine cancer	1.22e-05	0.000331	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—VEGFA—uterine cancer	1.22e-05	0.000331	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—NRAS—uterine cancer	1.21e-05	0.000327	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—RRM2—uterine cancer	1.2e-05	0.000325	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—DCN—uterine cancer	1.19e-05	0.000323	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.19e-05	0.000322	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STK11—uterine cancer	1.18e-05	0.00032	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCL2—uterine cancer	1.18e-05	0.000319	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—DCN—uterine cancer	1.16e-05	0.000315	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—POLD1—uterine cancer	1.15e-05	0.000311	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—RRM2—uterine cancer	1.13e-05	0.000306	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.13e-05	0.000306	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—STAR—uterine cancer	1.13e-05	0.000306	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.12e-05	0.000304	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—RRM2—uterine cancer	1.12e-05	0.000303	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SOCS3—uterine cancer	1.11e-05	0.0003	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—DCN—uterine cancer	1.1e-05	0.000297	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP11A1—uterine cancer	1.1e-05	0.000297	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—STK11—uterine cancer	1.09e-05	0.000296	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.09e-05	0.000296	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—DCN—uterine cancer	1.09e-05	0.000294	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.07e-05	0.000291	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—STK11—uterine cancer	1.07e-05	0.00029	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.07e-05	0.00029	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STK11—uterine cancer	1.07e-05	0.00029	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—STK11—uterine cancer	1.07e-05	0.00029	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.07e-05	0.00029	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL2—uterine cancer	1.07e-05	0.000288	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.06e-05	0.000287	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CDKN2B—uterine cancer	1.06e-05	0.000287	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.05e-05	0.000283	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—KRAS—uterine cancer	1.04e-05	0.000282	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKR1C3—uterine cancer	1.04e-05	0.00028	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.00028	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IGF1R—uterine cancer	1.03e-05	0.000279	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CXCL8—uterine cancer	1.03e-05	0.000277	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000277	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—MTHFR—uterine cancer	1.02e-05	0.000276	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.01e-05	0.000274	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—STK11—uterine cancer	1.01e-05	0.000274	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SOCS3—uterine cancer	1e-05	0.000271	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKR1C3—uterine cancer	9.76e-06	0.000264	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SMAD3—uterine cancer	9.68e-06	0.000262	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKR1C3—uterine cancer	9.68e-06	0.000262	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CDKN2B—uterine cancer	9.6e-06	0.00026	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—RRM2—uterine cancer	9.58e-06	0.000259	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PIK3CA—uterine cancer	9.56e-06	0.000259	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.49e-06	0.000257	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1R—uterine cancer	9.32e-06	0.000252	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CXCL8—uterine cancer	9.31e-06	0.000252	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—DCN—uterine cancer	9.3e-06	0.000252	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CXCL8—uterine cancer	9.28e-06	0.000251	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—STK11—uterine cancer	9.27e-06	0.000251	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP19A1—uterine cancer	9.27e-06	0.000251	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TP53—uterine cancer	9.25e-06	0.00025	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FGFR2—uterine cancer	9.23e-06	0.00025	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.05e-06	0.000245	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—POLD1—uterine cancer	8.87e-06	0.00024	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HRAS—uterine cancer	8.84e-06	0.000239	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SMAD3—uterine cancer	8.76e-06	0.000237	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP11A1—uterine cancer	8.76e-06	0.000237	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.7e-06	0.000235	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CXCL8—uterine cancer	8.43e-06	0.000228	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FGFR2—uterine cancer	8.36e-06	0.000226	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.29e-06	0.000224	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKR1C1—uterine cancer	8.29e-06	0.000224	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKR1C3—uterine cancer	8.27e-06	0.000224	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—STK11—uterine cancer	8.27e-06	0.000224	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP19A1—uterine cancer	8.27e-06	0.000224	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—MTHFR—uterine cancer	8.22e-06	0.000223	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—STK11—uterine cancer	8.07e-06	0.000218	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP19A1—uterine cancer	8.07e-06	0.000218	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—MTHFR—uterine cancer	8.06e-06	0.000218	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—MTHFR—uterine cancer	8.04e-06	0.000218	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ESR1—uterine cancer	7.9e-06	0.000214	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—AKT1—uterine cancer	7.81e-06	0.000211	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.76e-06	0.00021	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—STK11—uterine cancer	7.61e-06	0.000206	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP19A1—uterine cancer	7.61e-06	0.000206	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—MTHFR—uterine cancer	7.59e-06	0.000206	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—STK11—uterine cancer	7.54e-06	0.000204	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP19A1—uterine cancer	7.54e-06	0.000204	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—NRAS—uterine cancer	7.47e-06	0.000202	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.4e-06	0.0002	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—RRM2—uterine cancer	7.39e-06	0.0002	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—DCN—uterine cancer	7.18e-06	0.000194	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ESR1—uterine cancer	7.15e-06	0.000194	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.08e-06	0.000192	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—MTHFR—uterine cancer	6.96e-06	0.000188	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL2—uterine cancer	6.95e-06	0.000188	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.76e-06	0.000183	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—NRAS—uterine cancer	6.76e-06	0.000183	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.75e-06	0.000183	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.69e-06	0.000181	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—PIK3CA—uterine cancer	6.5e-06	0.000176	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—STK11—uterine cancer	6.44e-06	0.000174	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP19A1—uterine cancer	6.44e-06	0.000174	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—KRAS—uterine cancer	6.43e-06	0.000174	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.38e-06	0.000173	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL2—uterine cancer	6.3e-06	0.00017	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MTHFR—uterine cancer	6.21e-06	0.000168	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.14e-06	0.000166	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MTHFR—uterine cancer	6.07e-06	0.000164	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.05e-06	0.000164	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PIK3CA—uterine cancer	5.9e-06	0.00016	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	5.89e-06	0.000159	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—KRAS—uterine cancer	5.82e-06	0.000157	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ERBB2—uterine cancer	5.8e-06	0.000157	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.77e-06	0.000156	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MTHFR—uterine cancer	5.72e-06	0.000155	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTEN—uterine cancer	5.67e-06	0.000153	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MTHFR—uterine cancer	5.67e-06	0.000153	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL8—uterine cancer	5.5e-06	0.000149	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.48e-06	0.000148	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HRAS—uterine cancer	5.46e-06	0.000148	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—EP300—uterine cancer	5.41e-06	0.000146	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CDKN1B—uterine cancer	5.37e-06	0.000145	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	5.34e-06	0.000145	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	5.31e-06	0.000144	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ERBB2—uterine cancer	5.25e-06	0.000142	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	5.07e-06	0.000137	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.99e-06	0.000135	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL8—uterine cancer	4.98e-06	0.000135	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—STK11—uterine cancer	4.97e-06	0.000135	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.97e-06	0.000135	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HRAS—uterine cancer	4.95e-06	0.000134	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTEN—uterine cancer	4.94e-06	0.000134	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	4.86e-06	0.000132	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MTHFR—uterine cancer	4.84e-06	0.000131	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	4.82e-06	0.000131	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	4.81e-06	0.00013	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EP300—uterine cancer	4.72e-06	0.000128	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	4.59e-06	0.000124	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTEN—uterine cancer	4.58e-06	0.000124	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTEN—uterine cancer	4.48e-06	0.000121	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTEN—uterine cancer	4.48e-06	0.000121	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTEN—uterine cancer	4.47e-06	0.000121	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	4.47e-06	0.000121	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NRAS—uterine cancer	4.41e-06	0.000119	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT1—uterine cancer	4.37e-06	0.000118	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—EP300—uterine cancer	4.36e-06	0.000118	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—EP300—uterine cancer	4.27e-06	0.000116	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EP300—uterine cancer	4.27e-06	0.000116	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.27e-06	0.000115	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—EP300—uterine cancer	4.26e-06	0.000115	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTEN—uterine cancer	4.23e-06	0.000114	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—uterine cancer	4.04e-06	0.000109	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—EP300—uterine cancer	4.03e-06	0.000109	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CA—uterine cancer	4e-06	0.000108	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NRAS—uterine cancer	3.99e-06	0.000108	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTEN—uterine cancer	3.87e-06	0.000105	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KRAS—uterine cancer	3.8e-06	0.000103	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MTHFR—uterine cancer	3.74e-06	0.000101	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—EP300—uterine cancer	3.69e-06	0.0001	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	3.49e-06	9.44e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTEN—uterine cancer	3.46e-06	9.36e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KRAS—uterine cancer	3.44e-06	9.3e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTEN—uterine cancer	3.37e-06	9.13e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—uterine cancer	3.37e-06	9.13e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—EP300—uterine cancer	3.3e-06	8.92e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AKT1—uterine cancer	3.27e-06	8.84e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CA—uterine cancer	3.23e-06	8.74e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HRAS—uterine cancer	3.23e-06	8.73e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—EP300—uterine cancer	3.22e-06	8.71e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTEN—uterine cancer	3.18e-06	8.61e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CA—uterine cancer	3.16e-06	8.56e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	3.16e-06	8.55e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CA—uterine cancer	3.15e-06	8.54e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTEN—uterine cancer	3.15e-06	8.53e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—uterine cancer	3.05e-06	8.27e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—EP300—uterine cancer	3.03e-06	8.21e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—EP300—uterine cancer	3.01e-06	8.14e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CA—uterine cancer	2.98e-06	8.07e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HRAS—uterine cancer	2.92e-06	7.91e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT1—uterine cancer	2.85e-06	7.71e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.73e-06	7.4e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTEN—uterine cancer	2.69e-06	7.29e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKT1—uterine cancer	2.64e-06	7.14e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKT1—uterine cancer	2.58e-06	6.99e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT1—uterine cancer	2.58e-06	6.98e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKT1—uterine cancer	2.58e-06	6.98e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—EP300—uterine cancer	2.57e-06	6.95e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.44e-06	6.6e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKT1—uterine cancer	2.43e-06	6.59e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.38e-06	6.44e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.24e-06	6.07e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKT1—uterine cancer	2.23e-06	6.04e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.22e-06	6.02e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTEN—uterine cancer	2.08e-06	5.63e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKT1—uterine cancer	1.99e-06	5.39e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—EP300—uterine cancer	1.98e-06	5.37e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKT1—uterine cancer	1.94e-06	5.26e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.9e-06	5.14e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKT1—uterine cancer	1.83e-06	4.96e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKT1—uterine cancer	1.82e-06	4.92e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKT1—uterine cancer	1.55e-06	4.2e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.47e-06	3.97e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKT1—uterine cancer	1.2e-06	3.24e-05	CbGpPWpGaD
